Sullivan Lara → Pyxis Oncology, Inc. PYXS

Stake: 11.21% Shares: 7,543,007 CUSIP: 747324101 Class: Common Stock, par value $0.001 per share

Item 4 — Purpose of Transaction

Item 4 of the Schedule 13D is hereby amended and supplemented as follows: The response to Item 3 of this Amendment No. 5 is incorporated by reference herein.

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

4 13D/G filings on this issuer

3 other filings besides this one

Filer Track Record

2 filings by this filer

1 other filing in the data moat

Short Interest · settle 2026-07-15

DTC 3.11

3,253,653 shares short · +42.1% vs prior

Institutional Consensus · 2025-12-31

Held by elite portfolio managers

1 holder · $216K

Point72 Asset Mgmt

Post-Filing Returns · since 2025-03-31 on PYXS

+1 day

0.0%

+5 days

0.0%

+30 days

0.0%

+60 days

0.0%

+90 days

0.0%

+180 days

0.0%

Anchor price 3.07 on closest trading day on/after 2025-03-31. Source: Yahoo Finance daily adj_close (split + dividend adjusted).

Other 13D/G Filings on Pyxis Oncology, Inc.

Filed	Form	Filer	Stake	Shares
2026-07-10	SCHEDULE 13G	BIOTECHNOLOGY VALUE FUND L P	—	—	view →
2026-07-02	SCHEDULE 13G/A	GordonMD Global Investments LP	—	—	view →
2023-04-04	SC	Sullivan Lara	—	—	view →

Other Filings by Sullivan Lara

Filed	Form	Issuer	Stake	Shares
2023-04-04	SC	Pyxis Oncology, Inc. PYXS	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. From $49/mo.

See pricing →